Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery Versus Standard Therapy (IPPCollapse-II)

PHASE4CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

January 25, 2017

Primary Completion Date

November 19, 2018

Study Completion Date

November 19, 2018

Conditions
Colorectal SurgeryLaparoscopy
Interventions
PROCEDURE

IPP in colorectal laparoscopic surgery

Deep neuromuscular blockade can only be reversed with sugammadex, so in the IPP group, it will be used as neuromuscular blocking agent and its effect will be reversed with sugammadex (4mg / kg) at the end of the surgery. During surgery: deep neuromuscular blockade (PTC 1-5), Protective ventilation strategy, Optimal position and Pre stretching as a tool to decrease intraabdominal pressure maintaining optimal workspace.

PROCEDURE

SPP in colorectal laparoscopic surgery

A depolarizing neuromuscular blocking will be used (as routine clinical practice at each center) to maintain moderate neuromuscular blockade and its effect will be reversed with anticholinesterase at the end of the surgery. During surgery: Moderate neuromuscular blockade ( TOF 2-4) , position to surgeon criteria, no prestretching and Protective ventilation. Fixed IAP (12mmHg).

Trial Locations (1)

46026

Hospital universitario y Politécnico La Fe, Valencia

All Listed Sponsors
lead

Instituto de Investigacion Sanitaria La Fe

OTHER

NCT02773173 - Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery Versus Standard Therapy (IPPCollapse-II) | Biotech Hunter | Biotech Hunter